X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Patent (1638) 1638
Journal Article (1405) 1405
Conference Proceeding (75) 75
Publication (42) 42
Dissertation (3) 3
Book / eBook (2) 2
Book Chapter (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
performing operations (582) 582
transporting (582) 582
humans (496) 496
electricity (479) 479
chemistry (470) 470
metallurgy (467) 467
male (393) 393
physics (382) 382
female (339) 339
index medicus (310) 310
aged (292) 292
middle aged (281) 281
basic electric elements (266) 266
heating (225) 225
mechanical engineering (224) 224
blasting (223) 223
lighting (223) 223
weapons (223) 223
human necessities (213) 213
general tagging of cross-sectional technologies spanning over several sections of the ipc (206) 206
general tagging of new technological developments (206) 206
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (206) 206
electric solid state devices not otherwise provided for (186) 186
semiconductor devices (186) 186
oncology (173) 173
adult (167) 167
electric communication technique (158) 158
land vehicles for travelling otherwise than on rails (148) 148
chemical surface treatment (137) 137
coating by vacuum evaporation, by sputtering, by ion implantationor by chemical vapour deposition, in general (137) 137
coating material with metallic material (137) 137
coating metallic material (137) 137
diffusion treatment of metallic material (137) 137
inhibiting corrosion of metallic material or incrustation ingeneral (137) 137
coating by vacuum evaporation, by sputtering, by ionimplantation or by chemical vapour deposition, in general (136) 136
surface treatment of metallic material by diffusion into thesurface, by chemical conversion or substitution (136) 136
cycles (134) 134
technical subjects covered by former uspc (125) 125
vehicles in general (125) 125
surgery (117) 117
calculating (115) 115
computing (115) 115
counting (115) 115
aged, 80 and over (114) 114
prognosis (114) 114
technical subjects covered by former us classification (112) 112
cancer (111) 111
cycle axle suspensions (109) 109
cycle frames (109) 109
cycle side-cars, forecars, or the like (109) 109
cycle steering devices (109) 109
rider-operated terminal controls specially adapted forcycles (109) 109
hygiene (107) 107
medical or veterinary science (107) 107
measuring (103) 103
testing (103) 103
pictorial communication, e.g. television (102) 102
treatment outcome (102) 102
powered propulsion of sledges or (100) 100
rider propulsion of wheeled vehicles or sledges (100) 100
transmissions specially adapted for such vehicles (100) 100
cinematography (99) 99
electrography (99) 99
holography (99) 99
photography (99) 99
organic chemistry (98) 98
animals (97) 97
medicine & public health (94) 94
compositions based thereon (90) 90
organic macromolecular compounds (90) 90
preparations for medical, dental, or toilet purposes (90) 90
technologies or applications for mitigation or adaptation againstclimate change (90) 90
their preparation or chemical working-up (90) 90
gastroenterology & hepatology (80) 80
specific therapeutic activity of chemical compounds ormedicinal preparations (78) 78
games (77) 77
amusements (76) 76
analysis (76) 76
electrophotography (76) 76
magnetography (76) 76
sports (76) 76
apparatus for physical training, gymnastics, swimming,climbing, or fencing (75) 75
ball games (75) 75
conveying (75) 75
engineering elements and units (75) 75
general measures for producing and maintaining effectivefunctioning of machines or installations (75) 75
handling thin or filamentary material (75) 75
packing (75) 75
storing (75) 75
thermal insulation in general (75) 75
training equipment (75) 75
retrospective studies (74) 74
stomach neoplasms - pathology (74) 74
heterocyclic compounds (73) 73
working of plastics (72) 72
working of substances in a plastic state, in general (72) 72
cardiac & cardiovascular systems (66) 66
gastric cancer (66) 66
neoplasm staging (66) 66
stomach neoplasms - surgery (66) 66
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2928) 2928
Japanese (347) 347
French (240) 240
German (209) 209
Chinese (148) 148
Korean (22) 22
Finnish (5) 5
Swedish (5) 5
Norwegian (4) 4
Spanish (3) 3
Portuguese (2) 2
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1224 - 1235
Summary Background VEGFR-2 has a role in gastric cancer pathogenesis and progression. We assessed whether ramucirumab, a monoclonal antibody VEGFR-2... 
Hematology, Oncology and Palliative Medicine | SUPPORTIVE CARE | ONCOLOGY | BEVACIZUMAB | CLINICAL-TRIALS | GROWTH | 2ND-LINE CHEMOTHERAPY | OPEN-LABEL | 1ST-LINE THERAPY | COMBINATION | CANCER | III TRIAL | Confidence Intervals | Adenocarcinoma - pathology | Prognosis | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Stomach Neoplasms - pathology | Esophageal Neoplasms - pathology | Dose-Response Relationship, Drug | Esophageal Neoplasms - mortality | Adult | Female | Remission Induction - methods | Paclitaxel - administration & dosage | Double-Blind Method | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Esophagogastric Junction - pathology | Paclitaxel - adverse effects | Treatment Outcome | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Disease-Free Survival | Maximum Tolerated Dose | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged | Esophageal Neoplasms - drug therapy | Stomach Neoplasms - mortality | Adenocarcinoma - mortality | Antimitotic agents | Care and treatment | Hospitals | Clinical trials | Monoclonal antibodies | Product development | Antineoplastic agents | Vascular endothelial growth factor | Esophageal cancer
Journal Article
by Hitomi, Yuki and Hitomi, Yuki and Ueno, Kazuko and Ueno, Kazuko and Kawai, Yosuke and Kawai, Yosuke and Nishida, Nao and Nishida, Nao and Kojima, Kaname and Kawashima, Minae and Aiba, Yoshihiro and Nakamura, Hitomi and Kouno, Hiroshi and Kouno, Hirotaka and Kouno, Hirotaka and Ohta, Hajime and Ohta, Hajime and Sugi, Kazuhiro and Sugi, Kazuhiro and Nikami, Toshiki and Yamashita, Tsutomu and Katsushima, Shinji and Komeda, Toshiki and Ario, Keisuke and Naganuma, Atsushi and Naganuma, Atsushi and Shimada, Masaaki and Hirashima, Noboru and Hirashima, Noboru and Yoshizawa, Kaname and Yoshizawa, Kaname and Makita, Fujio and Furuta, Kiyoshi and Kikuchi, Masahiro and Kikuchi, Masahiro and Naeshiro, Noriaki and Naeshiro, Noriaki and Takahashi, Hironao and Mano, Yutaka and Yamashita, Haruhiro and Yamashita, Haruhiro and Matsushita, Kouki and Tsunematsu, Seiji and Yabuuchi, Iwao and Nishimura, Hideo and Shimada, Yusuke and Yamauchi, Kazuhiko and Yamauchi, Kazuhiko and Komatsu, Tatsuji and Komatsu, Tatsuji and Sugimoto, Rie and Sakai, Hironori and Mita, Eiji and Koda, Masaharu and Nakamura, Yoko and Kamitsukasa, Hiroshi and Sato, Takeaki and Nakamuta, Makoto and Masaki, Naohiko and Masaki, Naohiko and Takikawa, Hajime and Takikawa, Hajime and Tanaka, Atsushi and Ohira, Hiromasa and Ohira, Hiromasa and Zeniya, Mikio and Abe, Masanori and Abe, Masanori and Kaneko, Shuichi and Kaneko, Shuichi and Honda, Masao and Honda, Masao and Arai, Kuniaki and Arai, Kuniaki and Arinaga-Hino, Teruko and Hashimoto, Etsuko and Hashimoto, Etsuko and Taniai, Makiko and Taniai, Makiko and Umemura, Takeji and Umemura, Takeji and Joshita, Satoru and Nakao, Kazuhiko and Nakao, Kazuhiko and Ichikawa, Tatsuki and Ichikawa, Tatsuki and Shibata, Hidetaka and Shibata, Hidetaka and Takaki, Akinobu and Takaki, Akinobu and Yamagiwa, Satoshi and Seike, Masataka and Sakisaka, Shotaro and Takeyama, Yasuaki and Takeyama, Yasuaki and Harada, Masaru and Harada, Masaru and Senju, Michio and Senju, Michio and Yokosuka, Osamu and ...
Scientific reports, ISSN 2045-2322, 12/2019, Volume 9, Issue 1, pp. 102 - 11
Journal Article
Journal Article
Gastric Cancer, ISSN 1436-3291, 4/2013, Volume 16, Issue 2, pp. 175 - 182
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 20, pp. 1909 - 1919
Journal Article
Cancer Science, ISSN 1347-9032, 02/2016, Volume 107, Issue 2, pp. 149 - 154
Journal Article
Vaccine, ISSN 0264-410X, 06/2018, Volume 36, Issue 24, pp. 3423 - 3426
Therapeutic HPV vaccine is an agent to induce E7-specific Th1 immune responses to treat cervical neoplasia (CIN2-3). Our previous clinical trial has... 
Therapeutic HPV vaccine | Lactobacillus-based vaccine | Human papillomavirus (HPV) | Mucosal immunity | Cervical intraepithelial neoplasia (CIN) | Cervical cancer | MEDICINE, RESEARCH & EXPERIMENTAL | STRATEGY | PHASE-II | IMMUNOLOGY | CERVICAL INTRAEPITHELIAL NEOPLASIA | LESIONS | TRIAL | WOMEN | HIGH-GRADE | CASEI | Dose-Response Relationship, Immunologic | Papillomavirus Vaccines - genetics | Humans | Immunity, Mucosal | Papillomavirus E7 Proteins - immunology | Antigens, Viral - genetics | Human papillomavirus 16 - immunology | Th1 Cells - immunology | Papillomavirus E7 Proteins - genetics | Th1 Cells - virology | Papillomavirus E7 Proteins - secretion | Papillomavirus Infections - immunology | Female | Papillomavirus Infections - virology | Cervical Intraepithelial Neoplasia - immunology | Lactobacillus casei - genetics | Gene Expression | Genetic Vectors - chemistry | Administration, Oral | Immunization - methods | Interferon-gamma - secretion | Mice, Inbred C57BL | Uterine Cervical Neoplasms - prevention & control | Genetic Vectors - metabolism | Uterine Cervical Neoplasms - immunology | Lactobacillus casei - immunology | Cervical Intraepithelial Neoplasia - virology | Antigens, Viral - immunology | Animals | Genetic Engineering | Papillomavirus Infections - prevention & control | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Mice | Transgenes - immunology | Human papillomavirus 16 - genetics | Interferon-gamma - biosynthesis | Flow cytometry | Antigens | Immunization | Immunoglobulins | Immune response | Lactobacilli | Oral administration | Clinical trials | Lymphocytes T | Vaccines | Gene expression | Molecular chains | Optimization | Proteins | Human papillomavirus | γ-Interferon | Binding sites | Immune system
Journal Article
Human Molecular Genetics, ISSN 0964-6906, 12/2007, Volume 16, Issue 24, pp. 3017 - 3026
Journal Article
Journal Article
Vaccine, ISSN 0264-410X, 06/2018, Volume 36, Issue 24, p. 3423
Therapeutic HPV vaccine is an agent to induce E7-specific Th1 immune responses to treat cervical neoplasia (CIN2-3). Our previous clinical trial has... 
Papillomaviruses | Medical colleges | Immune response | Vaccines | Papillomavirus infections | Obstetrics | Cervical cancer
Journal Article